BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
162 hedge funds and large institutions have $2.42B invested in Blueprint Medicines in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 51 increasing their positions, 59 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% less funds holding
Funds holding: 188 → 162 (-26)
31% less capital invested
Capital invested by funds: $3.5B → $2.42B (-$1.08B)
62% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 37
Holders
162
Holding in Top 10
7
Calls
$10.1M
Puts
$7M
Top Buyers
| 1 | +$58.7M | |
| 2 | +$14.7M | |
| 3 | +$14.4M | |
| 4 |
Alkeon Capital Management
New York
|
+$12.1M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$10.1M |
Top Sellers
| 1 | -$112M | |
| 2 | -$16.7M | |
| 3 | -$10.9M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$8.52M |
| 5 |
State Street
Boston,
Massachusetts
|
-$8.1M |